Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Prepaid Assets (2016 - 2025)

Gyre Therapeutics (GYRE) has disclosed Prepaid Assets for 16 consecutive years, with $2.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Prepaid Assets rose 173.36% to $2.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.9 million, a 173.36% increase, with the full-year FY2024 number at $2.6 million, up 69.68% from a year prior.
  • Prepaid Assets was $2.9 million for Q3 2025 at Gyre Therapeutics, up from $2.7 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $8.5 million in Q1 2021 to a low of $697000.0 in Q2 2023.
  • A 5-year average of $3.1 million and a median of $1.8 million in 2024 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: plummeted 89.03% in 2022, then soared 355.92% in 2025.
  • Gyre Therapeutics' Prepaid Assets stood at $2.8 million in 2021, then plummeted by 69.97% to $843000.0 in 2022, then surged by 83.51% to $1.5 million in 2023, then surged by 69.68% to $2.6 million in 2024, then rose by 9.45% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Prepaid Assets are $2.9 million (Q3 2025), $2.7 million (Q2 2025), and $8.2 million (Q1 2025).